These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35654172)

  • 1. Regulation of endothelial nitric oxide synthase in cardiac remodeling.
    Musicante M; Kim HH; Chen Y; Liao F; Bhattacharya SK; Lu L; Sun Y
    Int J Cardiol; 2022 Oct; 364():96-101. PubMed ID: 35654172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.
    Fandl HK; Garcia VP; Treuth JW; Brewster LM; Greiner JJ; Davy KP; Stauffer BL; Desouza CA
    Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H675-H685. PubMed ID: 36930654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.
    Bubikat A; De Windt LJ; Zetsche B; Fabritz L; Sickler H; Eckardt D; Gödecke A; Baba HA; Kuhn M
    J Biol Chem; 2005 Jun; 280(22):21594-9. PubMed ID: 15793309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS; Agata J; Xia CF; Chao L; Chao J
    Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
    Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency.
    Shakeri H; Boen JRA; De Moudt S; Hendrickx JO; Leloup AJA; Jacobs G; De Meyer GRY; De Keulenaer GW; Guns PDF; Segers VFM
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2416-H2428. PubMed ID: 33989083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
    Kundu S; Kumar M; Sen U; Mishra PK; Tyagi N; Metreveli N; Lominadze D; Rodriguez W; Tyagi SC
    J Cell Biochem; 2009 Jan; 106(1):119-26. PubMed ID: 19021146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression.
    Flaherty MP; Brown M; Grupp IL; Schultz JE; Murphree SS; Jones WK
    Cardiovasc Toxicol; 2007; 7(3):165-77. PubMed ID: 17901560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis.
    Kazakov A; Müller P; Jagoda P; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2012 Mar; 93(3):397-405. PubMed ID: 22106415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.
    Teekakirikul P; Eminaga S; Toka O; Alcalai R; Wang L; Wakimoto H; Nayor M; Konno T; Gorham JM; Wolf CM; Kim JB; Schmitt JP; Molkentin JD; Norris RA; Tager AM; Hoffman SR; Markwald RR; Seidman CE; Seidman JG
    J Clin Invest; 2010 Oct; 120(10):3520-9. PubMed ID: 20811150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice.
    Vignon-Zellweger N; Relle K; Rahnenführer J; Schwab K; Hocher B; Theuring F
    Life Sci; 2014 Nov; 118(2):219-25. PubMed ID: 24355292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes.
    Wenzel S; Rohde C; Wingerning S; Roth J; Kojda G; Schlüter KD
    Hypertension; 2007 Jan; 49(1):193-200. PubMed ID: 17075027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension.
    Nergui S; Fukumoto Y; Do E Z; Nakajima S; Shimizu T; Ikeda S; Elias-Al-Mamun M; Shimokawa H
    Circ J; 2014; 78(6):1465-74. PubMed ID: 24705390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
    Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
    Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
    Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
    Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.